G A Baker

Author PubWeight™ 63.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 In utero antiepileptic drug exposure: fetal death and malformations. Neurology 2006 3.64
2 Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology 2010 2.38
3 Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 2008 2.24
4 The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study. Epilepsia 1996 2.00
5 Patients' experiences of injury as a result of epilepsy. Epilepsia 1997 1.73
6 Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 2005 1.63
7 In utero exposure to levetiracetam vs valproate: development and language at 3 years of age. Neurology 2014 1.52
8 The development, reliability and validity of a disease specific quality of life model for adults with growth hormone deficiency. Clin Endocrinol (Oxf) 1996 1.47
9 Psychogenic non-epileptic seizures--definition, etiology, treatment and prognostic issues: a critical review. Seizure 2009 1.30
10 Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study. Seizure 2009 1.28
11 Reality monitoring and psychotic hallucinations. Br J Clin Psychol 1991 1.21
12 Cross-cultural differences in health-related quality of life of people with epilepsy: findings from a European study. Qual Life Res 1999 1.20
13 A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. Health Technol Assess 2007 1.18
14 Factors influencing compliance with antiepileptic drug regimes. Seizure 1997 1.18
15 Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years. Neurology 2012 1.15
16 A randomized controlled trial of a health promotion education programme for people with multiple sclerosis. Clin Rehabil 2006 1.09
17 Child development following in utero exposure: levetiracetam vs sodium valproate. Neurology 2011 1.06
18 Failure to recognize psychogenic nonepileptic seizures may cause death. Neurology 2004 1.06
19 Adverse antiepileptic drug effects in new-onset seizures: a case-control study. Neurology 2011 1.04
20 Effects of temperature on calcium-sensitive fluorescent probes. Biophys J 2000 1.04
21 The use of the Canadian occupational performance measure as an outcome of a pain management program. Can J Occup Ther 2001 1.03
22 Psychogenic non-epileptic seizures--diagnostic issues: a critical review. Clin Neurol Neurosurg 2008 1.01
23 Non-epileptic attack disorder (NEAD): a comprehensive review. Seizure 1999 1.00
24 The behavioral consequences of exposure to antiepileptic drugs in utero. Epilepsy Behav 2008 0.99
25 Unfolding of acrylodan-labeled human serum albumin probed by steady-state and time-resolved fluorescence methods. Biophys J 1998 0.99
26 Quality of life after epilepsy surgery. J Neurol Neurosurg Psychiatry 1997 0.98
27 Measuring the impact of multiple sclerosis on psychosocial functioning: the development of a new self-efficacy scale. Clin Rehabil 2001 0.96
28 Quality of life in treated head and neck cancer patients: a preliminary report. Clin Otolaryngol Allied Sci 1984 0.95
29 The association of sexual and physical abuse with somatization: characteristics of patients presenting with irritable bowel syndrome and non-epileptic attack disorder. Psychol Med 1999 0.94
30 Knowledge gaps and uncertainties about epilepsy: findings from an ethnographic study in China. Epilepsy Behav 2008 0.90
31 Seizure frequency, patient-perceived seizure severity and the psychosocial consequences of intractable epilepsy. Epilepsy Res 1991 0.89
32 The SF-36 as a health status measure for epilepsy: a psychometric assessment. Qual Life Res 1999 0.86
33 Significance of radiocontaminants in 123I for dosimetry and scintillation camera imaging. J Nucl Med 1976 0.86
34 Non-epileptic attack disorder: a psychological perspective. Seizure 1997 0.85
35 Advances in methods for assessing the impact of epilepsy and antiepileptic drug therapy on patients' health-related quality of life. Qual Life Res 1995 0.85
36 Patient-based assessments of quality of life in newly diagnosed epilepsy patients: validation of the NEWQOL. Epilepsia 2000 0.83
37 A parallel multiharmonic frequency-domain fluorometer for measuring excited-state decay kinetics following one-, two-, or three-photon excitation. Anal Chem 1998 0.83
38 Differential effects of antiepileptic drugs on neonatal outcomes. Epilepsy Behav 2012 0.83
39 The Neurotoxicity Scale--II. Results of a patient-based scale assessing neurotoxicity in patients with epilepsy. Epilepsy Res 1997 0.82
40 Psychological treatments for epilepsy. Cochrane Database Syst Rev 2005 0.82
41 Reliability, validity and responsiveness of a revised scoring system for the Liverpool Seizure Severity Scale. Epilepsy Res 2001 0.81
42 The A-B neuropsychological assessment schedule (ABNAS): the relationship between patient-perceived drug related cognitive impairment and results of neuropsychological tests. Seizure 2002 0.80
43 Psychometric properties and factor structure of the Wechsler Memory Scale-Revised in a sample of persons with intractable epilepsy. J Clin Exp Neuropsychol 1997 0.80
44 Lamotrigine add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2001 0.80
45 Validation of the Wechsler Memory Scale-Revised in a sample of people with intractable temporal lobe epilepsy. Epilepsia 1996 0.80
46 Knowledge of and attitudes expressed toward epilepsy by carers of people with epilepsy: a UK perspective. Epilepsy Behav 2007 0.79
47 The detection of malingering in memory performance: the sensitivity and specificity of four measures in a UK population. Br J Clin Psychol 2005 0.79
48 The A-B neuropsychological assessment schedule (ABNAS): the further refinement of a patient-based scale of patient-perceived cognitive functioning. Epilepsy Res 2001 0.78
49 Behavioral and cognitive effects of lamotrigine. J Child Neurol 1997 0.78
50 Stress and avoidance in Pseudoseizures: testing the assumptions. Epilepsy Res 1999 0.78
51 Interaction of influenza virus fusion peptide with lipid membranes: effect of lysolipid. J Membr Biol 2006 0.78
52 Epilepsy, pseudoseizures and perceived family characteristics: a controlled study. Epilepsy Res 1994 0.78
53 The contribution of the measurement of seizure severity to quality of life research. Qual Life Res 1995 0.78
54 Lamotrigine add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2000 0.78
55 Neuropsychological outcomes in randomized controlled trials of antiepileptic drugs: a systematic review of methodology and reporting standards. Epilepsia 1998 0.78
56 Neuropsychological assessment of a group of UK patients with Cohen syndrome. Neuropediatrics 2003 0.77
57 Self-management education for children with epilepsy. Cochrane Database Syst Rev 2007 0.77
58 Self-management education for adults with epilepsy. Cochrane Database Syst Rev 2007 0.77
59 Kinetics and thermodynamics of free flavins and the flavin-based redox active site within glucose oxidase dissolved in solution or sequestered within a sol-gel-derived glass. Anal Chem 1999 0.76
60 Psychological treatments for epilepsy. Cochrane Database Syst Rev 2003 0.76
61 Health-related quality of life after transient ischemic attack and minor stroke: is medical or surgical treatment influential? J Stroke Cerebrovasc Dis 2007 0.76
62 Simulating a memory impairment: can amnesics implicitly outperform simulators? Br J Clin Psychol 1998 0.75
63 Effect of psychotropic agents upon the blastogenic response of human t-lymphocytes. Biol Psychiatry 1977 0.75
64 Detecting the faking of amnesia: a comparison of the effectiveness of three different techniques for distinguishing simulators from patients with amnesia. J Clin Exp Neuropsychol 1999 0.75
65 Psychological treatments for epilepsy. Cochrane Database Syst Rev 2001 0.75
66 Linkage and redox isomerism in ruthenium complexes of catecholate, semiquinone, and o-acylphenolate ligands derived from 1,2-dihydroxy-9,10-anthracenedione (alizarin) and related species: syntheses, characterizations, and photophysics. Inorg Chem 2000 0.75
67 Analysis of genetic changes in finite populations composed of mixtures of pure lines. J Theor Biol 1964 0.75
68 Towards a comprehensive neuropsychological service in the United Kingdom for adult patients being considered for epilepsy surgery. Seizure 1994 0.75
69 Effects of ethanol volume percent on fluorescein-labeled spinach apo- and holocalmodulin. Anal Chem 2000 0.75
70 Stress in midwifery: a comparison of midwives and nurses using the Work Environment Scale. Int J Nurs Stud 1994 0.75
71 Patients' experiences of and satisfaction with care for their epilepsy. Epilepsia 1996 0.75
72 Letter: Effects of nutrition on schizophrenia. Am J Psychiatry 1973 0.75
73 Stochastic processes and genotypic frequencies under mixed selfing and random mating. J Theor Biol 1964 0.75
74 Molecular dynamics ensemble, equation of state, and ergodicity. Phys Rev E Stat Nonlin Soft Matter Phys 2000 0.75